Grape King Bio Ltd.(TW:1707)
NT$78.70-0.60 (-0.76%)
TW:1707
Grape King Bio Ltd. financials statements
NT$78.70
At close:-0.60 (-0.76%)
Grape King Bio Ltd. (1707) Income Statement
Grape King Bio Ltd. Income Statement
Last quarter (Q2 2026), Grape King Bio Ltd.'s total revenue was NT$2.41B, a decrease of 6.09% from the same quarter last year. In Q2, Grape King Bio Ltd.'s net income was NT$232.25M. See Grape King Bio Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 10.25B | NT$ 11.16B | NT$ 10.64B | NT$ 10.39B | NT$ 9.80B | |
| NT$ 7.70B | NT$ 8.66B | NT$ 8.54B | NT$ 8.48B | NT$ 7.86B | |
| NT$ 5.56B | NT$ 6.16B | NT$ 6.04B | NT$ 5.93B | NT$ 5.54B | |
| Depreciation and Amortization | NT$ 547.88M | NT$ 513.48M | NT$ 459.76M | NT$ 449.64M | NT$ 416.40M |
| NT$ 2.69B | NT$ 3.17B | NT$ 3.12B | NT$ 3.13B | NT$ 2.83B | |
| NT$ 2.14B | NT$ 2.50B | NT$ 2.50B | NT$ 2.69B | NT$ 2.42B | |
| NT$ 156.19M | NT$ 173.45M | NT$ 163.96M | NT$ 128.15M | NT$ 103.32M | |
| NT$ 2.30B | NT$ 2.67B | NT$ 2.66B | NT$ 2.69B | NT$ 2.41B | |
| NT$ 1.22B | NT$ 1.45B | NT$ 1.45B | NT$ 2.17B | NT$ 1.95B | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 8.22 | NT$ 9.79 | NT$ 9.81 | NT$ 14.65 | NT$ 13.20 |
| Diluted EPS | NT$ 8.17 | NT$ 9.75 | NT$ 9.74 | NT$ 14.56 | NT$ 13.13 |
| Weighted Average Shares Outstanding | 226.39M | 148.14M | 148.09M | 148.14M | 147.55M |
| Weighted Average Shares Outstanding (Diluted) | 226.39M | 149.16M | 149.12M | 149.06M | 148.40M |
Currency in TWD
